logo

RARE

Ultragenyx·NASDAQ
--
--(--)
--
--(--)
2.90 / 10
Underperform

Fundamental evaluation presents weak characteristics (2.9/10). Strengths encompass Profit-MV and Cash-MV, however risks emerge in Revenue-MV and Current assets turnover ratio. This justifies defensive view.

Fundamental(2.9)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.76
Score1/3
Weight10.49%
1M Return5.20%
Inventory turnover ratio
Value1.64
Score2/3
Weight-3.98%
1M Return-2.63%
Gross profit margin (%)
Value82.90
Score2/3
Weight2.59%
1M Return1.47%
Profit-MV
Value0.46
Score2/3
Weight15.70%
1M Return7.79%
PB-ROE
Value1.14
Score2/3
Weight22.04%
1M Return10.68%
Current assets turnover ratio
Value0.64
Score1/3
Weight-0.79%
1M Return-0.48%
Fixed assets turnover ratio
Value1.81
Score2/3
Weight0.20%
1M Return0.12%
Asset-MV
Value-0.50
Score2/3
Weight35.82%
1M Return15.13%
Cash-MV
Value-0.07
Score2/3
Weight15.72%
1M Return7.73%
Net profit / Total profit (%)
Value100.71
Score2/3
Weight2.22%
1M Return1.28%
Is RARE fundamentally strong?
  • RARE scores 2.90/10 on fundamentals and holds a Premium valuation at present. Backed by its -320.66% ROE, -91.95% net margin, -4.47 P/E ratio, 147.31 P/B ratio, and 6.61% earnings growth, these metrics solidify its Underperform investment rating.